310 related articles for article (PubMed ID: 8698875)
21. Autoantibody to CD40 ligand in systemic lupus erythematosus: association with thrombocytopenia but not thromboembolism.
Nakamura M; Tanaka Y; Satoh T; Kawai M; Hirakata M; Kaburaki J; Kawakami Y; Ikeda Y; Kuwana M
Rheumatology (Oxford); 2006 Feb; 45(2):150-6. PubMed ID: 16188945
[TBL] [Abstract][Full Text] [Related]
22. Elevated levels and functional capacity of soluble CD40 ligand in systemic lupus erythematosus sera.
Vakkalanka RK; Woo C; Kirou KA; Koshy M; Berger D; Crow MK
Arthritis Rheum; 1999 May; 42(5):871-81. PubMed ID: 10323442
[TBL] [Abstract][Full Text] [Related]
23. Effects of preactivated autologous T lymphocytes on CD80, CD86 and CD95 expression by chronic lymphocytic leukemia B cells.
Romano C; De Fanis U; Sellitto A; Dalla Mora L; Chiurazzi F; Giunta R; Rotoli B; Lucivero G
Leuk Lymphoma; 2003 Nov; 44(11):1963-71. PubMed ID: 14738151
[TBL] [Abstract][Full Text] [Related]
24. Human dendritic cells activate T lymphocytes via a CD40: CD40 ligand-dependent pathway.
McLellan AD; Sorg RV; Williams LA; Hart DN
Eur J Immunol; 1996 Jun; 26(6):1204-10. PubMed ID: 8647193
[TBL] [Abstract][Full Text] [Related]
25. Regulation of CD40 ligand expression in systemic lupus erythematosus.
Crow MK; Kirou KA
Curr Opin Rheumatol; 2001 Sep; 13(5):361-9. PubMed ID: 11604589
[TBL] [Abstract][Full Text] [Related]
26. gamma/delta T lymphocytes express CD40 ligand and induce isotype switching in B lymphocytes.
Horner AA; Jabara H; Ramesh N; Geha RS
J Exp Med; 1995 Mar; 181(3):1239-44. PubMed ID: 7869041
[TBL] [Abstract][Full Text] [Related]
27. Peripheral blood lymphocytes in SLE--hyperexpression of CD154 on T and B lymphocytes and increased number of double negative T cells.
Devi BS; Van Noordin S; Krausz T; Davies KA
J Autoimmun; 1998 Oct; 11(5):471-5. PubMed ID: 9802931
[TBL] [Abstract][Full Text] [Related]
28. Anti-CD40 ligand antibody treatment prevents the development of lupus-like nephritis in a subset of New Zealand black x New Zealand white mice. Response correlates with the absence of an anti-antibody response.
Early GS; Zhao W; Burns CM
J Immunol; 1996 Oct; 157(7):3159-64. PubMed ID: 8816428
[TBL] [Abstract][Full Text] [Related]
29. CD40L overexpression on T cells and monocytes from patients with systemic lupus erythematosus is resistant to calcineurin inhibition.
Katsiari CG; Liossis SN; Dimopoulos AM; Charalambopoulo DV; Mavrikakis M; Sfikakis PP
Lupus; 2002; 11(6):370-8. PubMed ID: 12139375
[TBL] [Abstract][Full Text] [Related]
30. Anti-CD40 antibody KPL-404 inhibits T cell-mediated activation of B cells from healthy donors and autoimmune patients.
Marken J; Muralidharan S; Giltiay NV
Arthritis Res Ther; 2021 Jan; 23(1):5. PubMed ID: 33407802
[TBL] [Abstract][Full Text] [Related]
31. The role of CD40-CD40 ligand interactions in suppression of human B cell responsiveness by CD4+ T cells.
Hirohata S
Cell Immunol; 1997 Nov; 182(1):20-8. PubMed ID: 9427806
[TBL] [Abstract][Full Text] [Related]
32. B cells regulate expression of CD40 ligand on activated T cells by lowering the mRNA level and through the release of soluble CD40.
van Kooten C; Gaillard C; Galizzi JP; Hermann P; Fossiez F; Banchereau J; Blanchard D
Eur J Immunol; 1994 Apr; 24(4):787-92. PubMed ID: 7512028
[TBL] [Abstract][Full Text] [Related]
33. Glucocorticoids inhibit CD40 ligand expression of peripheral CD4+ lymphocytes.
Bischof F; Melms A
Cell Immunol; 1998 Jul; 187(1):38-44. PubMed ID: 9682002
[TBL] [Abstract][Full Text] [Related]
34. CD40 ligand-positive CD8+ T cell clones allow B cell growth and differentiation.
Hermann P; Van-Kooten C; Gaillard C; Banchereau J; Blanchard D
Eur J Immunol; 1995 Oct; 25(10):2972-7. PubMed ID: 7589100
[TBL] [Abstract][Full Text] [Related]
35. Undetectable CD40 ligand expression on T cells and low B cell responses to CD40 binding agonists in human newborns.
Durandy A; De Saint Basile G; Lisowska-Grospierre B; Gauchat JF; Forveille M; Kroczek RA; Bonnefoy JY; Fischer A
J Immunol; 1995 Feb; 154(4):1560-8. PubMed ID: 7530739
[TBL] [Abstract][Full Text] [Related]
36. Induction of B cell costimulatory function by recombinant murine CD40 ligand.
Kennedy MK; Mohler KM; Shanebeck KD; Baum PR; Picha KS; Otten-Evans CA; Janeway CA; Grabstein KH
Eur J Immunol; 1994 Jan; 24(1):116-23. PubMed ID: 7517359
[TBL] [Abstract][Full Text] [Related]
37. A common SNP in the CD40 region is associated with systemic lupus erythematosus and correlates with altered CD40 expression: implications for the pathogenesis.
Vazgiourakis VM; Zervou MI; Choulaki C; Bertsias G; Melissourgaki M; Yilmaz N; Sidiropoulos P; Plant D; Trouw LA; Toes RE; Kardassis D; Yavuz S; Boumpas DT; Goulielmos GN
Ann Rheum Dis; 2011 Dec; 70(12):2184-90. PubMed ID: 21914625
[TBL] [Abstract][Full Text] [Related]
38. E4BP4 overexpression: a protective mechanism in CD4+ T cells from SLE patients.
Zhao M; Liu Q; Liang G; Wang L; Luo S; Tang Q; Zhao H; Su Y; Yung S; Chan TM; Lu Q
J Autoimmun; 2013 Mar; 41():152-60. PubMed ID: 23340290
[TBL] [Abstract][Full Text] [Related]
39. Kinetics of expression and subset distribution of the TNF superfamily members CD40 ligand and Fas ligand on T lymphocytes in cattle.
Hirano A; Brown WC; Trigona W; Tuo W; Estes DM
Vet Immunol Immunopathol; 1998 Feb; 61(2-4):251-63. PubMed ID: 9613439
[TBL] [Abstract][Full Text] [Related]
40. Hyperexpression of CD40 ligand (CD154) in inflammatory bowel disease and its contribution to pathogenic cytokine production.
Liu Z; Colpaert S; D'Haens GR; Kasran A; de Boer M; Rutgeerts P; Geboes K; Ceuppens JL
J Immunol; 1999 Oct; 163(7):4049-57. PubMed ID: 10491009
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
